Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Jones

Showing results (71-80 of 273) with videos related to

Pageof 28
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 10, 2015
Depression and Outcome of Fear of Falling in a Falls Prevention ProgramAndrea Iaboni, Carol Banez, Robert Lam, et al.
The Journal of Rheumatology|December 4, 2009
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosusHannes Cash, Manfred Relle, Julia Menke, et al.
The American Journal of Surgical Pathology|June 25, 2016
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase DeficiencyBeth L Thurberg, Melissa P Wasserstein, Simon A Jones, et al.
Pediatric Research|September 3, 2015
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 ySimon A Jones, Martin Bialer, Rossella Parini, et al.
Journal of Hospital Medicine|November 4, 2020
Trends in COVID-19 Risk-Adjusted Mortality RatesLeora I Horwitz, Simon A Jones, Robert J Cerfolio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2006
Sleep enhances IL-6 trans-signaling in humansStoyan Dimitrov, Tanja Lange, Christian Benedict, et al.
Orphanet Journal of Rare Diseases|June 18, 2022
Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher diseaseAimee Donald, Cecilia Kämpe Björkvall, Ashok Vellodi, et al.
Orphanet Journal of Rare Diseases|February 28, 2021
Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfaBethanie Garside, Jan Hoong Ho, See Kwok, et al.
Molecular Genetics and Metabolism|November 30, 2025
Vascular complications and imaging-based cardiovascular risk assessment in Mucopolysaccharidoses: A systematic reviewEamon P McCarron, Victoria Burgess, Steven K Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cellsSuzanne M Hurst, Rachel M McLoughlin, James Monslow, et al.
Pageof 28

Showing results (71-80 of 273) with videos related to

Sort By:
Pageof 28
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 10, 2015
Depression and Outcome of Fear of Falling in a Falls Prevention ProgramAndrea Iaboni, Carol Banez, Robert Lam, et al.
The Journal of Rheumatology|December 4, 2009
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosusHannes Cash, Manfred Relle, Julia Menke, et al.
The American Journal of Surgical Pathology|June 25, 2016
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase DeficiencyBeth L Thurberg, Melissa P Wasserstein, Simon A Jones, et al.
Pediatric Research|September 3, 2015
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 ySimon A Jones, Martin Bialer, Rossella Parini, et al.
Journal of Hospital Medicine|November 4, 2020
Trends in COVID-19 Risk-Adjusted Mortality RatesLeora I Horwitz, Simon A Jones, Robert J Cerfolio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2006
Sleep enhances IL-6 trans-signaling in humansStoyan Dimitrov, Tanja Lange, Christian Benedict, et al.
Orphanet Journal of Rare Diseases|June 18, 2022
Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher diseaseAimee Donald, Cecilia Kämpe Björkvall, Ashok Vellodi, et al.
Orphanet Journal of Rare Diseases|February 28, 2021
Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfaBethanie Garside, Jan Hoong Ho, See Kwok, et al.
Molecular Genetics and Metabolism|November 30, 2025
Vascular complications and imaging-based cardiovascular risk assessment in Mucopolysaccharidoses: A systematic reviewEamon P McCarron, Victoria Burgess, Steven K Rogers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cellsSuzanne M Hurst, Rachel M McLoughlin, James Monslow, et al.
Pageof 28